379 results
Page 9 of 19
8-K
ed0ai
2 Feb 11
Discovery Labs Provides Expanded Update Regarding its Program for Surfaxin® U.S. Marketing Authorization
12:00am
8-K
t0q6acm6
10 Jan 11
Discovery Labs Provides Update Regarding its Program for Surfaxin® U.S. Marketing Authorization
12:00am
DEFA14A
le6v739lo3ti7f
3 Dec 10
Additional proxy soliciting materials
12:00am
8-K
di5a8xg3
3 Dec 10
Discovery Labs Receives Nasdaq Delisting Notification
12:00am
CORRESP
16h4i3424kxs2ws5fw
10 Nov 10
Correspondence with SEC
12:00am
8-K
6q7jczjaqeh hjyrcqnx
9 Nov 10
Results of Operations and Financial Condition
12:00am
CORRESP
smbufba9w7q
8 Nov 10
Correspondence with SEC
12:00am
424B5
eadbqk
13 Oct 10
Prospectus supplement for primary offering
12:00am
8-K
v9cdtdexc4575nh ni
15 Sep 10
Departure of Directors or Certain Officers
12:00am
8-K
n2rgk9751n5
4 Aug 10
Discovery Labs Provides Business Update and Reports Second Quarter 2010 Financial Results
12:00am
424B5
r4xl uqdw
18 Jun 10
Prospectus supplement for primary offering
12:00am
424B5
soy47c
16 Jun 10
Prospectus supplement for primary offering
12:00am
424B3
ohroop81
15 Jun 10
Prospectus supplement
12:00am
8-K
t3lzaxsbrj1e yxy
4 Jun 10
Discovery Labs Announces Listing Transfer to NASDAQ Capital Market
12:00am
8-K
dt308f
21 May 10
Discovery Labs Achieves Key Milestone Towards Potential Surfaxin® Approval
12:00am